Recently, the Sei Foundation stated on its official X account that it is actively exploring the acquisition of the bankrupt genetic testing company 23andMe to protect the genetic privacy of 15 million American users and store their data on the blockchain. Following the news, the market reacted quickly, with the SEI token price briefly rising by 3%.

The Sei Foundation pointed out that user data sovereignty has risen to a national security issue. When a pioneering American biotech company faces bankruptcy, the genomic data of millions of people could fall into the hands of third parties lacking transparency or with different values, bringing privacy and security risks. To this end, Sei hopes to ensure data security through blockchain technology and empower users with control over their own data.

The Sei Foundation's vision includes:

● Running 23andMe on the Sei blockchain: Deploying 23andMe on the Sei blockchain to leverage its high performance and immutable ledger characteristics, ensuring data security and transparency.

● Data sovereignty belongs to users: Through encryption and confidential transmission, users will be able to control their genetic data, preventing data misuse or trading without consent.

● Data monetization shared by users: Users will be able to decide how to monetize their data and share in the profits, realizing shared data value.

After the announcement, the market showed strong interest in the Sei Foundation's DeSci strategy, looking favorably on the prospect of gene data storage on the blockchain.

The Sei Foundation stated that this acquisition plan is not only to save a company in distress but also to build a future where data sovereignty belongs to users. In this future, users will be able to autonomously control their most sensitive and private information, rather than becoming "commodities" for large corporations or other institutions.

The Sei Foundation expects to release more acquisition progress and related notifications in the future.